ACP
GSK icon

Aveo Capital Partners’s GSK GSK Stock Holding History

Aveo Capital Partners’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-4,798
Closed -$209K – 340
2024
Q1 		$209K Buy
+4,798
New +$198K 0.02% 350
2022
Q3 		– Sell
-5,684
Closed -$309K – 284
2022
Q2 		$309K Buy
5,684
+243
+4% +$13.4K 0.05% 219
2022
Q1 		$296K Sell
5,441
-1,341
-20% -$72.8K 0.05% 219
2021
Q4 		$374K Buy
+6,782
New +$353K 0.07% 203

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Aveo Capital Partners's GSK Position: Q2 2024 in Review

Aveo Capital Partners sold out of GSK (GSK) in Q2 2024, closing a stake of 4,798 shares — an estimated $209K sold.

Aveo Capital Partners first reported a position in GSK in Q4 2021 and held it in 4 quarters. The position peaked at $374K in Q4 2021. 884 funds tracked by Wall St. Rank hold GSK as of Q2 2024.

  • Aveo Capital Partners reported no remaining GSK position as of Q2 2024 after selling out during the quarter.
  • Aveo Capital Partners sold 4,798 GSK shares in Q2 2024, an estimated $209K.
  • Aveo Capital Partners first reported a position in GSK in Q4 2021 and held it in 4 quarters.
  • Aveo Capital Partners's GSK position peaked at $374K in Q4 2021.
  • 884 funds tracked by Wall St. Rank held GSK as of Q2 2024.

Based on Aveo Capital Partners's 13F filing for Q2 2024, filed 2 Aug 2024.